Suggested Topics within your search.
Showing 621 - 640 results of 710 for search '(("clinical practice guideline") OR ("clinical practice guidelines"))', query time: 0.13s Refine Results
  1. 621

    Sequencing and Integration of Cervical Manual Therapy and Vestibulo-oculomotor Therapy for Concussion Symptoms: Retrospective Analysis by Christopher Kevin Wong, Lauren Ziaks, Samantha Vargas, Tessia DeMattos, Chelsea Brown

    Published 2021-02-01
    “…# Background After concussion many people have cervicogenic headache, visual dysfunction, and vestibular deficits that can be attributed to brain injury, cervical injury, or both. While clinical practice guidelines outline treatments to address the symptoms that arise from the multiple involved systems, no preferred treatment sequence for post-concussion syndrome has emerged…”
    Get full text
    Article
  2. 622

    Phase II single vs hypofractionated irradiation for timely access to partial breast radiotherapy (SHIFT-PB) by Robert Olson, Marjorie Cua, Quinn Matthews, Jordanna Laing, Dylan Narinesingh, Alan Nichol, Tanya Berrang, Theodora Koulis, Tania Karan, Nick Chng

    Published 2025-08-01
    “…Various dose fractionation schedules for PBI have been recommended in clinical practice guidelines. In British Columbia (BC), a dose of 26 Gy in 5 fractions has been adopted. …”
    Get full text
    Article
  3. 623

    A pharmacist-led educational and audit & feedback strategy to reduce antibiotic prescription in primary care: the AFA study by A. Soler, A. Huguet, A. Leiva, C. Vicens, F. Bejarano-Romero, E. Sempere, T. Izquierdo, M. M. Parera, R. Seco, M. Fages, A. Medina, L. Castillo-Palomares, E. López-Guerrero, B. A. Ferrer, L. Ugarriza, M. Llarena, L. Gallardo-Alfaro, AFA study investigators

    Published 2025-07-01
    “…Ethics and dissemination The study was approved by the Balearic island, Valencia and IDIAP Jordi Gol Ethical Committee, follows the Declaration of Helsinki, Good Clinical Practice guidelines, and applicable national and European regulations concerning clinical trials and data protection. …”
    Get full text
    Article
  4. 624

    Distinct immunity dynamics of natural killer cells in mild and moderate COVID-19 cases during the Omicron variant phase by Yukari Nishikawa, Kosuke Yamaguchi, Ma’arif Athok Shofiudin, Momone Mimura, Miyako Takata, Shu Mihara, Takeru Kawakami, Ayumu Doi, Risa Matsuda, Hiroyuki Kato, Ryo Okamoto, Kengo Mukuda, Naoki Kinoshita, Kensaku Okada, Tsuyoshi Kitaura, Masaki Nakamoto, Hisashi Noma, Yusuke Endo, Akira Yamasaki, Hiroki Chikumi

    Published 2025-05-01
    “…Of these, 11 and 16 were diagnosed with mild and moderate COVID-19, respectively, based on the Japanese COVID-19 clinical practice guideline. Peripheral blood NK cell subsets and surface markers, including the activating receptor NKG2D and the inhibitory receptor TIGIT, as well as serum levels of 24 immunoregulatory markers, such as cytokines and cytotoxic mediators, were measured at admission and recovery. …”
    Get full text
    Article
  5. 625

    Osteonecrosis of the jaw in patients with clear cell renal cell carcinoma treated with targeted agents: a case series and large-scale pharmacovigilance analysis by Shuyun Wang, Shuyun Wang, Rui Zhang, Song Wang, Qian Guo, Qian Guo, Donghong Yin, Yan Song, Xianhua She, Xuyan Wang, Jinju Duan

    Published 2024-10-01
    “…TKIs and ICIs are limited to drugs that treat renal cancer recommended by the National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology for Kidney Cancer.MethodsWe described a case series of patients experiencing ONJ while on TKIs or ICIs. …”
    Get full text
    Article
  6. 626

    Phase I/II trial of intracerebral transplantation of autologous bone marrow stem cells combined with recombinant peptide scaffold for patients with chronic intracerebral haemorrhag... by Arisa Miura, Yoichi M Ito, Masahito Kawabori, Miki Fujimura, Kaoru Kahata, Hideo Shichinohe, Kenichiro Maeda, Masahiko Mukaino, Ryo Kogawa, Kentaro Nakamura, Shuho Gotoh, Kota Kurisu

    Published 2024-12-01
    “…Neurological assessments, MRI, 18F-fluorodeoxyglucose positron emission tomography and 123I-Iomazenil single-photon emission CT will be performed for 1 year after administration.Ethics and dissemination The trial protocols were reviewed and approved by the Institutional Review Board of the Hokkaido University Hospital (R5-11), and this study is conducted according to Good Clinical Practice guidelines and the principles of the Declaration of Helsinki. …”
    Get full text
    Article
  7. 627

    Proportion and clinical characteristics of metabolic-associated fatty liver disease and associated liver fibrosis in an urban Chinese population by Mengmeng Hou, Qi Gu, Jiawei Cui, Yao Dou, Xiuhong Huang, Jie Li, Liang Qiao, Yuemin Nan, Yuanyuan Ji

    Published 2025-04-01
    “…The diagnosis of MAFLD was based on the established clinical practice guidelines. The fibrosis-4 index score (FIB-4) was employed to evaluate hepatic fibrosis, with a FIB-4 score of ≥1.3 indicating significant fibrosis. …”
    Get full text
    Article
  8. 628

    ‘Effects of a home-based bimodal lifestyle intervention in frail patients with end-stage liver disease awaiting orthotopic liver transplantation’: study protocol of a non-randomise... by Hans Blokzijl, Vincent E de Meijer, Rienk Dekker, Joost M Klaase, Coby Annema, Bart C Bongers, Allard G Wijma, Job AM van der Palen, Frans JC Cuperus

    Published 2024-01-01
    “…Finally, feasibility of the programme will be assessed by monitoring the participation rate and reasons for non-participation, number and severity of adverse events, and dropout rate and reasons for dropout.Ethics and dissemination This study was approved by the Medical Research Ethics Committee of the UMCG (registration number NL83612.042.23, August 2023) and is registered in the Clinicaltrials.gov register (NCT05853484). Good Clinical Practice guidelines and the principles of the Declaration of Helsinki will be applied. …”
    Get full text
    Article
  9. 629

    Prospects for the Use of NGAL and KIM-1 for the Diagnosis of Acute Kidney Injury in Patients Receiving Antibacterial Therapy by E. Yu. Nikitin, V. N. Drozdov, M. A. Vyzhigina, O. A. Vorobieva, A. A. Astapovskiy, K. N. Khalaidzheva, E. V. Shikh

    Published 2022-08-01
    “…The developers of Clinical Practice Guidelines for Acute Kidney Injury titled The Initiative to Improve Global Kidney Disease Outcomes (KDIGO) point at the need of new biomarkers for diagnosis acute kidney injury (AKI).The objective: to study and evaluate the diagnostic significance of the levels of neutrophil gelatinase-associated lipocalin (NGAL) and kidney injury molecule-1 (KIM-1) in patients with AKI in the early postoperative period when antibiotic therapy is used.Subjects and Methods. …”
    Get full text
    Article
  10. 630

    Dietary nutrient intake and nutritional status in maintenance hemodialysis patients: a multicenter cross-sectional survey by Zhi-Qian Chen, Li Luo, Xin-Xin Chen, Xiao-Yu Zhang, Shu-Qing Yin, Guang-Hui Xiao, Na Xu, Qun Liu, Chun-Yan Su

    Published 2024-12-01
    “…Among them, 225 (58.9%) and 233 (61.0%) patients’ protein and energy intake did not meet the recommendations outlined in the National Kidney Foundation’s Kidney Disease Outcomes Quality Initiative Clinical Practice Guideline for Nutrition in Chronic Kidney Disease (2020 update). …”
    Get full text
    Article
  11. 631

    Radiomics in the differential diagnosis of glioblastoma under the primary neurooncoimaging conditions by Nikita E. Maslov, Daria A. Valenkova, Alexander M. Sinitсa, Gennadiy E. Trufanov, Vladimir M. Moiseenko, Alexander Yu. Efimtsev, Vera V. Chernobrivtseva

    Published 2025-04-01
    “…According to the 2021 WHO Classification of Tumors of the Central Nervous System (CNS) and the 2023 Clinical Practice Guidelines on the Drug Management of Primary CNS Cancers, the first step of molecular genetic testing to identify the morphological type and malignancy of adult-type diffuse gliomas is the detection of isocitrate dehydrogenase (IDH) mutation status. …”
    Get full text
    Article
  12. 632

    Novel Versus Conventional Sequencing of β-Blockers, Sodium/Glucose Cotransportor 2 Inhibitors, Angiotensin Receptor-Neprilysin Inhibitors, and Mineralocorticoid Receptor Antagonist... by Sumanth Karamchand, Tsungai Chipamaunga, Poobalan Naidoo, Kiolan Naidoo, Virendra Rambiritch, Kevin Ho, Robert Chilton, Kyle McMahon, Rory Leisegang, Hellmuth Weich, Karim Hassan

    Published 2025-03-01
    “…ConclusionsWe envisage that this study will help support evidence-based medicine and inform clinical practice guidelines on the optimal rate of sequencing of anti–heart failure therapies. …”
    Get full text
    Article
  13. 633

    Progestogens in women with threatened miscarriage or recurrent miscarriage: A meta‐analysis by Yunli Zhao, Rohan D'Souza, Ya Gao, Qiukui Hao, Lucas Kallas‐Silva, Jeremy P. Steen, Gordon Guyatt

    Published 2024-09-01
    “…Abstract Introduction Clinical practice guidelines provide inconsistent recommendations regarding progestogen supplementation for threatened and recurrent miscarriage. …”
    Get full text
    Article
  14. 634

    Correlation of polymorphous variants (ApaI, TagI, BsmI) of the VDR receptor gene with the vitamin D level and liver fibrosis in children with autoimmune hepatitis by V. S. Berezenko, Kh. Z. Mykhailiuk, Z. I. Rossokha, S. P. Kyriachenko

    Published 2019-07-01
    “…In all children, the diagnosis was confirmed in accordance with the International Guidelines for the study of liver diseases (European Association for the Study of Liver (EASL) Clinical Practice Guidelines: Autoimmune Hepatitis, 2015). In the examined children, the elastography of the liver parenchyma was performed by the shear wave method. …”
    Get full text
    Article
  15. 635

    Evaluation of the Glucose-Lowering Effect of Bloodletting Therapy in Type 2 Diabetes Mellitus by Tserentogtokh Baasantogtokh, Sainbileg Sonomtseren, Tsolmon Unurjargal, Rinchyenkhand Myagmardorj, Vaanchigsuren Seesregdorj, Bayarmagnai Lkhagvasuren, Vankhuu Enkhtuya, Seesregdorj Surenjid

    Published 2024-12-01
    “…Both groups received medicine according to the Mongolian Clinical Practice Guidelines for T2DM treatment. The experimental group additionally underwent bloodletting therapy on Day 6 of the study, following a 5-day preparation period during which they consumed 2.0 grams of a “3-seed decoction” (twice daily). …”
    Get full text
    Article
  16. 636

    Analysis of the Consumption of Medicinal Products Associated with a High Risk of Drug-Induced Liver Injury in Patients with COVID-19 by V. I. Petrov, A. Yu. Ryazanova, N. S. Tokareva

    Published 2024-10-01
    “…The authors identified medicines capable of causing clinically apparent liver damage (according to the LiverTox database and Russian clinical practice guidelines) and/or elevated liver enzymes in ≥1% of patients (according to safety reports).RESULTS. …”
    Get full text
    Article
  17. 637
  18. 638

    The Role of Cardiac Computed Tomography Angiography in Risk Stratification for Coronary Artery Disease by Sophie E. van Rosendael, MD, PhD, Arthur Shiyovich, MD, Rhanderson N. Cardoso, MD, Camila Veronica Souza Freire, MD, Alexander R. van Rosendael, MD, PhD, Fay Y. Lin, MD, Gina Larocca, MD, Solomon W. Bienstock, MD, Ron Blankstein, MD, Leslee J. Shaw, PhD

    Published 2024-11-01
    “…Along with these technological advancements, there has been additional high-quality evidence for CCTA including large randomized clinical trials supporting high-level recommendations from many international clinical practice guidelines. Current trials largely compare a CCTA vs functional testing strategy, yet there is minimal evidence on CCTA plaque-guided therapeutic trials to measure regression of atherosclerosis and prevention of major coronary artery disease events. …”
    Get full text
    Article
  19. 639

    Phase 2 trial design of BMS-986278, a lysophosphatidic acid receptor 1 (LPA1) antagonist, in patients with idiopathic pulmonary fibrosis (IPF) or progressive fibrotic interstitial... by Jeffrey J Swigris, Toby M Maher, Tamera J Corte, Aryeh Fischer, Hong Xiao, Lisa Lancaster, Takafumi Suda, Xiaojiang Zhan, Jonathan G Goldin, Scott M Palmer, Hideaki Watanabe, Takashi Ogura, Anne Minnich, Giridhar S Tirucherai, Brandon Elpers, R Adam Smith, Edgar D Charles

    Published 2021-01-01
    “…The primary endpoint is rate of change in per cent predicted forced vital capacity from baseline to week 26 in the IPF cohort.Ethics and dissemination This study will be conducted in accordance with Good Clinical Practice guidelines, Declaration of Helsinki principles, and local ethical and legal requirements. …”
    Get full text
    Article
  20. 640

    Protocol for a multicentre, randomised, parallel-control, superiority trial comparing administration of clotting factor concentrates with a standard massive haemorrhage protocol in... by Neil Parry, Andrew Beckett, Jo Carroll, Homer Tien, Jeannie Callum, Andrew Petrosoniak, Damon Scales, Luis Teodoro da Luz, Keyvan Karkouti, Paul T Engels, Hans-Peter Hucke, Deep Grewal, Bruce Schwartz, Henry Peng

    Published 2021-09-01
    “…After enrolment of 120 patients, a preplanned adaptive interim analysis will be conducted to reassess assumptions, check for early superiority demonstration or reassess the sample size for remainder of the study.Ethics and dissemination The study has been approved by local and provincial research ethics boards and will be conducted according to the Declaration of Helsinki, Good Clinical Practice guidelines and regulatory requirements. As per the Tri-Council Policy Statement, patient consent will be deferred due to the emergency nature of the interventions. …”
    Get full text
    Article